Search details
1.
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein.
PLoS One
; 19(4): e0301773, 2024.
Article
in English
| MEDLINE | ID: mdl-38593167
2.
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.
Nat Commun
; 14(1): 1309, 2023 03 10.
Article
in English
| MEDLINE | ID: mdl-36894558
3.
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.
Commun Med (Lond)
; 3(1): 75, 2023 May 26.
Article
in English
| MEDLINE | ID: mdl-37237062
4.
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.
Nat Commun
; 13(1): 1699, 2022 03 31.
Article
in English
| MEDLINE | ID: mdl-35361754
5.
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle.
NPJ Vaccines
; 7(1): 74, 2022 Jun 30.
Article
in English
| MEDLINE | ID: mdl-35773301
6.
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine
; 40(9): 1289-1298, 2022 02 23.
Article
in English
| MEDLINE | ID: mdl-35101265
7.
Genotypic and functional properties of early infant HIV-1 envelopes.
Retrovirology
; 8: 67, 2011 Aug 15.
Article
in English
| MEDLINE | ID: mdl-21843318
8.
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.
NPJ Vaccines
; 6(1): 61, 2021 Apr 19.
Article
in English
| MEDLINE | ID: mdl-33875658
9.
Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
Virology
; 550: 21-26, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32866728
10.
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain.
Sci Immunol
; 5(47)2020 05 01.
Article
in English
| MEDLINE | ID: mdl-32358170
11.
Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
PLoS One
; 13(6): e0199452, 2018.
Article
in English
| MEDLINE | ID: mdl-29920563
12.
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.
J Clin Invest
; 114(9): 1334-42, 2004 Nov.
Article
in English
| MEDLINE | ID: mdl-15520866
13.
Core bead chromatography for preparation of highly pure, infectious respiratory syncytial virus in the negative purification mode.
Vaccine
; 34(32): 3690-6, 2016 07 12.
Article
in English
| MEDLINE | ID: mdl-27238375
14.
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner.
PLoS One
; 10(6): e0130517, 2015.
Article
in English
| MEDLINE | ID: mdl-26107373
15.
Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.
Hum Vaccin Immunother
; 8(11): 1638-47, 2012 Nov 01.
Article
in English
| MEDLINE | ID: mdl-23151449
16.
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
Virology
; 371(1): 98-107, 2008 Feb 05.
Article
in English
| MEDLINE | ID: mdl-17950773
17.
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.
J Virol
; 79(14): 8828-34, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15994776
18.
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
J Virol
; 79(22): 14161-8, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16254351
19.
Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
Nat Immunol
; 6(3): 247-52, 2005 Mar.
Article
in English
| MEDLINE | ID: mdl-15685174
20.
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
J Immunol
; 174(11): 7179-85, 2005 Jun 01.
Article
in English
| MEDLINE | ID: mdl-15905562